Showing results (1-10 of 172) with videos related to
Sort By:
Pageof 18
Drug Intelligence & Clinical Pharmacy|June 1, 1984
Heparin interferes with tobramycin serum concentration determinations by EmitG R Matzke, K Piveral, C E Halstenson, et al.Clinical Pharmacology and Therapeutics|July 1, 1985
Cefotaxime and desacetyl cefotaxime kinetics in renal impairmentG R Matzke, P A Abraham, C E Halstenson, et al.Journal of Clinical Hypertension|December 1, 1987
Comparison of antihypertensive, renal hemodynamic, and humoral effects of pinacidil and hydralazine monotherapyP A Abraham, C E Halstenson, G R Matzke, et al.International Journal of Clinical Pharmacology, Therapy, and Toxicology|December 1, 1986
The effect of hemodialysis on piperacillin pharmacokineticsK L Heim-Duthoy, C E Halstenson, P A Abraham, et al.Drug Intelligence & Clinical Pharmacy|November 1, 1983
Bumetanide: a new loop diuretic (Bumex, Roche Laboratories)C E Halstenson, G R MatzkePharmacotherapy|September 1, 1985
Antihypertensive therapy with once-daily administration of terazosin, a new alpha 1-adrenergic-receptor blockerP A Abraham, C E Halstenson, G R Matzke, et al.American Journal of Nephrology|January 1, 1988
Suprofen-induced uricosuria. A potential mechanism for acute nephropathy and flank painP A Abraham, C E Halstenson, J A Opsahl, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 1, 1987
Systemic absorption of oral vancomycin in patients with renal insufficiency and antibiotic-associated colitisG R Matzke, C E Halstenson, P L Olson, et al.Antimicrobial Agents and Chemotherapy|January 1, 1990
Effect of concomitant administration of piperacillin on the dispositions of netilmicin and tobramycin in patients with end-stage renal diseaseC E Halstenson, C A Hirata, K L Heim-Duthoy, et al.Journal of Clinical Pharmacology|March 1, 1987
Gentamicin disposition in young and elderly patients with various degrees of renal functionG R Matzke, J J Jameson, C E HalstensonPageof 18